do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline Can patients take and inhibitors together? Neuroprotection by dipeptidyl-peptidase-4 inhibitors and
Description
doi: 10.1111/dom.14465 237 ElSayedNAAleppoGArodaVRBannuruRRBrownFMBruemmerDet al

Endocrinology 153: 3054-3065, 2012

Week 5 reassessment: Check inflammatory markers (CRP, ESR, relevant condition-specific markers)

If a dose is missed, simply resume your regular schedule the following day

Most protocols start with the lowest available dose and increase gradually over weeks to months
